The MDD Interview, Part II: Varian maintains its focus on the beam with proton therapy April 24, 2014 By John Brosky
The MDD Interview Part I: Varian seen advancing with precision in proton therapy April 17, 2014 By John Brosky
Report from Europe: Theraclion initial public offering to fund HIFU breast surgery April 17, 2014 By John Brosky
Report from Europe: Focus shifts from sales to costs for French startups April 14, 2014 By John Brosky
The MDD Interview, Part II: Closing the window on open-end reimbursements April 3, 2014 By John Brosky
The MDD Interview: AAA builds on diagnostic tracers to create nuclear drugs March 27, 2014 By John Brosky
